SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-22-005492
Filing Date
2022-04-08
Accepted
2022-04-08 08:01:08
Documents
6
Period of Report
2022-05-19

Document Format Files

Seq Description Document Type Size
1 DEF 14A kpti-def14a-2022.htm DEF 14A 2963176
2 GRAPHIC img83249951_0.jpg GRAPHIC 33329
3 GRAPHIC img83249951_1.jpg GRAPHIC 8774
4 GRAPHIC img83249951_2.jpg GRAPHIC 33329
5 GRAPHIC img83249951_3.jpg GRAPHIC 504087
6 GRAPHIC img83249951_4.jpg GRAPHIC 510527
  Complete submission text file 0000950170-22-005492.txt   4464818
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36167 | Film No.: 22815434
SIC: 2834 Pharmaceutical Preparations